East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Naproxen + Esomeprazole
Vimovo
Not routinely available
SMC (734/11)
07/11/2011

Indication

For the symptomatic treatment of osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis (AS), in patients who are at risk for developing non-steroidal anti-inflammatory drug (NSAID)-associated gastric and/or duodenal ulcers and where treatment with lower doses of naproxen or of ot...

For the symptomatic treatment of osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis (AS), in patients who are at risk for developing non-steroidal anti-inflammatory drug (NSAID)-associated gastric and/or duodenal ulcers and where treatment with lower doses of naproxen or of other NSAIDs is not considered sufficient.

Therapeutic Area

Musculoskeletal and joint diseases

Status Description

Not routinely available as not recommended for use in NHSScotland

Formulation

500mg/20mg modified release tablets

Comments

None

Link to Advice

734/11

Advice Published

07/11/2011

SMC Submission Type

Full

SMC Status

Not recommended